Quantcast

Maryland State Wire

Tuesday, April 22, 2025

Maryland: Biologics companies were the second most FDA inspected companies in Maryland in February

Webp 51tcce8qtq0gv3h0ttdr040fsao9

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

In February, two Biologics companies received two FDA inspections in Maryland, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Maryland, equalling 25% of all inspections in February.

Of all the Maryland companies involved in Biologics, Johns Hopkins Hospital Blood Bank received the most citations from the FDA in February.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Maryland During February
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products11
Drug Quality Assurance1
Food Composition, Standards, Labeling and Econ1
Foodborne Biological Hazards3
Monitoring of Marketed Animal Drugs, Feed, and Devices1

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS